Halozyme Therapeutics
HALO
#2379
Rank
โ‚น699.99 B
Marketcap
โ‚น5,931
Share price
1.94%
Change (1 day)
8.32%
Change (1 year)

Revenue for Halozyme Therapeutics (HALO)

Revenue in 2025 (TTM): โ‚น122.58 Billion

According to Halozyme Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น130.97 Billion. an increase over the revenue in the year 2024 that were of โ‚น87.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Halozyme Therapeutics from 2002 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น125.37 B43.94%
2024 โ‚น87.10 B26.17%
2023 โ‚น69.03 B26.38%
2022 โ‚น54.62 B65.55%
2021 โ‚น32.99 B68.6%
2020 โ‚น19.57 B40.02%
2019 โ‚น13.97 B31.62%
2018 โ‚น10.61 B-47.47%
2017 โ‚น20.21 B102.8%
2016 โ‚น9.96 B11.07%
2015 โ‚น8.97 B87.98%
2014 โ‚น4.77 B41.03%
2013 โ‚น3.38 B46.09%
2012 โ‚น2.31 B-21.89%
2011 โ‚น2.96 B385.99%
2010 โ‚น0.61 B-3.76%
2009 โ‚น0.63 B50.59%
2008 โ‚น0.42 B182.5%
2007 โ‚น0.14 B242.93%
2006 โ‚น43.48 M
2003 โ‚น0.8 M-80.8%
2002 โ‚น4.2 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น8.833 T 6,644.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.868 T 4,380.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น6.112 T 4,566.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น5.056 T 3,760.90%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
โ‚น1.054 T 705.09%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚น29.42 B-77.53%๐Ÿ‡บ๐Ÿ‡ธ USA